C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2004
11/18/2004	US20040229366 Combinations of genes for producing seed plants exhibiting modulated reproductive development
11/18/2004	US20040229365 Method to control gene expression in bacteria, namely Rhizobiaceae, to improve root nodule development, nitrogen fixation and plant biomass production
11/18/2004	US20040229364 Comprises nucleotide sequences coding trehalose-6-phosphate phosphatase for enhancing water stress tolerance in plants; tissue engineering
11/18/2004	US20040229363 Using osilating wave electroporation to increase membrane premeability and transfer heterologous nucleotide sequences and vectors into competent cells; bioreactors for generating exogenous proteins
11/18/2004	US20040229362 Method for producing non-pathogenic helper virus-free preparations of herpes virus amplicon vectors, the helper virus & the cells used in this method, the corresponding genetic tools, as well as the applications of these non-pathogenic amplicon vectors
11/18/2004	US20040229361 Mammalian cell line for use as tool in preparation of gene transfer sequences; tissue engineering; bioreactor for production of therapeutic proteins
11/18/2004	US20040229360 Transgenic ventricle tissue for use as tools in screening modulators and treatments for cardiovascular disorders; tissue targeted therapy
11/18/2004	US20040229359 Cloning vectors and vector components
11/18/2004	US20040229358 Inhibition of gene expression by delivery of small interfering RNA to post-embryonic animal cells in vivo
11/18/2004	US20040229357 Gibberellin 2-oxidase
11/18/2004	US20040229346 Micro-particle array analysis system, micro-particle array kit, and chemical analysis method
11/18/2004	US20040229344 polymerase chain reaction (PCR); a buffered, aqueous DNA-containing extract is prepared at ambient temperature from a cell-containing sample of soil, water, or particle-containing aerosol from the environment; Cells are lysed to release DNA into buffer; N-phenacylthiazolium bromide (PTB)
11/18/2004	US20040229341 Transgenic pichia comprising nucleotide sequences coding chitin deacetylase; bioreactor for generation of chitosan to be used in agriculture, food, drugs and cosmetic; protein precipitation and metal chelating agent
11/18/2004	US20040229339 Comprises neisseria membrane protein for use as tool in generation of vaccine to prevent infection and sepsis in infants
11/18/2004	US20040229338 Using transgenic and attenuated salmonella comprising tumor modulatory proteins and pharmceutical conjugate to treat cell proliferative disorders; targeted tissue therapy
11/18/2004	US20040229335 Methods and compositions for the production of adenoviral vectors
11/18/2004	US20040229332 Extracting and purifying enzymes
11/18/2004	US20040229331 Novel human kinase and polynucleotides encoding the same
11/18/2004	US20040229320 Method for procucing L-amino acid using bacterium, belonging to the genus Escherichia, lacking active mlc gene
11/18/2004	US20040229317 Nucleotide sequences coding amino acid transport protein for use in identifying modulator for treatment of cell proliferative and tissue distribution disorders
11/18/2004	US20040229314 22438, 23553, 25278, and 26212 novel human sulfatases
11/18/2004	US20040229313 Sialyltransferases from C. jejuni
11/18/2004	US20040229312 Serine protease ligand comprising protease inhibitor domain for use in treatment of inflammation, infection, cell proliferative, skin, liver and respiratory disorders
11/18/2004	US20040229311 Enzymatic protein comprising lysine decarboxylase activity for biosynthesis of lysine in transgenic methylophilus; bioreactors
11/18/2004	US20040229309 GANP protein
11/18/2004	US20040229308 Kinesin polypeptide for use in identifying modulators for detection, treatment or prevention of cancer, nervous system and vesicular transport disorders
11/18/2004	US20040229306 URA5 gene and methods for stable genetic integration in yeast
11/18/2004	US20040229304 Transport proteins; for drug screening/diagnosis/therapy; genetic engineering; bacteriophages
11/18/2004	US20040229289 Antigen binding peptides (abtides) from peptide libraries
11/18/2004	US20040229286 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
11/18/2004	US20040229277 Compositions and methods for the diagnosis and treatment of tumor
11/18/2004	US20040229274 Synaptic activation protein compositions and method
11/18/2004	US20040229272 Beta 1,3-galactosyltransferases from C. jejuni
11/18/2004	US20040229271 Compositions and methods for the identification and selection of nucleic acids and polypeptides
11/18/2004	US20040229270 in vitro drug design and development; psoralen production
11/18/2004	US20040229266 RNA interference mediating small RNA molecules
11/18/2004	US20040229263 Comprises campylobacter glycosyltransferase for use in synthesis of lipooligosaccharide (LOS); ganglioside biosynthesis and mimetics for treatment of nervous system disorders
11/18/2004	US20040229260 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases
11/18/2004	US20040229255 Using fermentive processing to preparing lysine in trehalose 6-phosphate synthase attenuated coryneform bacterium; for use in medicines, cosmetics and nutraceuticals
11/18/2004	US20040229248 cyanine, xanthene, porphyrin or coumarin dyes, used for marking probes, including nucleic acids and proteins
11/18/2004	US20040229243 MarA family helix-turn-helix domains and their methods of use
11/18/2004	US20040229242 Methods of capturing, detecting and quantifying RNA:DNA hybrids and a modified RNase H useful therein
11/18/2004	US20040229241 Comprises nucleotide sequences coding amine oxidase for use in identifying modulator for treatment of neoplastic cell proliferation and differentiation; antitumor/anticarcinogenic agents
11/18/2004	US20040229239 Comprises nucleotide sequences coding g-protein coupled receptors for identifying modulators of taste enhancement; food processing and drug design; screening tastants
11/18/2004	US20040229238 Comprises kinesin polypeptides for use as tools in identifying modulators for the treatment and prevention of cancer, neurological and vesicular transport disorders
11/18/2004	US20040229236 preparing pristinamycin IIA and/or IIB by introducing a disabling mutation into a gene that encodes 3-hydroxypicolinic acid:adenosine 5'-monopiosphate ligase; selecting and culturing cells containing the mutated gene that are blocked in the production of pristinamycin IA and IB
11/18/2004	US20040229235 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis
11/18/2004	US20040229234 Determining RNA expression patterns of tissues propagated in three dimension collagen matrix; genomics; disease diagnosis and transcriptional expression patterns
11/18/2004	US20040229232 Compositions and methods for the diagnosis and treatment of tumor
11/18/2004	US20040229230 Method for gene isolation by Cre-trap cloning
11/18/2004	US20040229229 Use of multiple recombination sites with unique specificity in recombinational cloning
11/18/2004	US20040229222 An array of capture probes, hybridizing the target sequence to an array of capture probes to form a hybridization complex and determining the nucleotide at the detection position; amplification to prevent self-extension; sensitivity
11/18/2004	US20040229213 Exhaustive analysis of viral protein interactions by two-hybrid screens and selection of correctly folded viral interacting polypeptides
11/18/2004	US20040229212 Recombinant human mannan-binding lectin
11/18/2004	US20040228920 HoxD3, HoxA3, and HoxB3 compositions and methods for improved wound healing
11/18/2004	US20040228878 Recombinant infectious laryngotracheitis virus and uses thereof
11/18/2004	US20040228877 Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof
11/18/2004	US20040228876 Composition and Method for Treating Cancer Using Herpes Virus
11/18/2004	US20040228870 Methods for promoting growth of bone, ligament, and cartilage
11/18/2004	US20040228867 Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases
11/18/2004	US20040228865 Prevention and treatment of amyloidogenic disease
11/18/2004	US20040228859 inhibit binding of IGF-1 and IGF-II to IGF-IR so they act as antitumor by reducing tumor growth and/or prolonging the time of tumor progression; hybridoma cell lines; methods of preparing the compositions
11/18/2004	US20040228857 administration of a human or humanized antibody expressed and glycosylated in a chinese hamster ovaries (CHO) cell expression system to treat T-cell mediated disorders, autoimmune disorders, cancer and infections; vasculitis, arthritis, lupus, psoriasis, multiple sclerosis, graft versus host disease
11/18/2004	US20040228843 Preparing chimeric expression vector for use as gene transfer tool in heterologous gene expression; tissue engineering
11/18/2004	US20040228842 Compositions and methods for cytomegalovirus treatment
11/18/2004	US20040228841 Replication-competent herpes simplex virus mediates destruction of neoplastic cells
11/18/2004	US20040228840 Vector for integration of heterologous sequences into poxviral genomes
11/18/2004	US20040228838 Viral interleukin-6
11/18/2004	DE19882755B4 Ein Fusionsprotein des hEGF und des humanen Angiogenins und ein Verfahren zu dessen Herstellung A fusion protein of hEGF and human angiogenin, and a process for its preparation
11/18/2004	DE10319478A1 siRNA-Selektionsverfahren siRNA selection process
11/18/2004	DE10317877A1 Verfahren zur Herstellung von Sporidiobolus ruineniae Stämmen mit verbesserter Coenzym Q10-Produktion Process for the preparation of Sporidiobolus ruineniae strains with improved coenzyme Q10 production
11/18/2004	DE10315834A1 Humane Nukleinsäuresequenzen aus Pankreaskarzinomen Nucleic acid sequences from human pancreatic cancer
11/18/2004	DE10297331T5 Behandlung und Diagnose von Insulin-resistenten Zuständen Treatment and diagnosis of insulin-resistant conditions
11/18/2004	DE10261650A1 Verwendung des multifunktionellen Transkriptionsfaktors Yin-Yang-1 und Varianten davon zur Behandlung von Erkrankungen, insbesondere von Typ-1 Diabetes Use of the multifunctional transcription factor Yin Yang 1 and variants thereof for the treatment of diseases, especially of type 1 diabetes
11/18/2004	CA2684022A1 Mesoderm and definitive endoderm cell populations
11/18/2004	CA2526341A1 Variant subtilisin enzymes (subtilases)
11/18/2004	CA2525493A1 Human blood proteins expressed in monocot seeds
11/18/2004	CA2525387A1 Glucose dehydrogenase and its preparation
11/18/2004	CA2524912A1 An autologous upregulation mechanism allowing optimized cell type-specific and regulated gene expression cells
11/18/2004	CA2524799A1 Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production
11/18/2004	CA2524623A1 Immunogenic human tnf alpha analogues with reduced cytotoxicity and methods of their preparation
11/18/2004	CA2524528A1 Truncated forms of human dbf4, complexes with their interacting partners and methods for identification of inhibitors thereof
11/18/2004	CA2524493A1 Corn event tc1507 and methods for detection thereof
11/18/2004	CA2524393A1 Solid phase cell lysis and capture platform
11/18/2004	CA2524293A1 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
11/18/2004	CA2524172A1 Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses
11/18/2004	CA2524057A1 Minicircle vector production
11/18/2004	CA2523870A1 Claudins' underexpression as markers of tumor metastasis
11/18/2004	CA2523770A1 Method for identifying modulators of clk-1 and ubif activity
11/18/2004	CA2523764A1 Isolated bacillus mhkcel cellulase
11/18/2004	CA2523722A1 Novel bacillus bagcel cellulase
11/18/2004	CA2523720A1 Synthetic gene encoding human carcinoembryonic antigen and uses thereof
11/18/2004	CA2523400A1 Variant lipolytic enzymes
11/18/2004	CA2519680A1 Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
11/18/2004	CA2500523A1 Vp2-modified raav vector compositions and uses therefor
11/18/2004	CA2487058A1 Mesoderm and definitive endoderm cell populations
11/17/2004	WO2004107200A1 System and method for controlling user interface properties with data
11/17/2004	EP1477910A1 Apparatus for managing gene expression data
11/17/2004	EP1477806A1 Method of determining ligand
11/17/2004	EP1477565A1 Method of producing L-lysine by fermentation

1 ... 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 ... 4023